Dear Friends and Colleagues,
Dalian BITeomics, Inc (BIT) is a leading meeting organizer of biosciences in China. BIT is pleased to co-organize and sponsor our Serial Event II extended from the Anniversary Congress of International Drug Discovery Science and Technology (IDDST), the aim of which is to promote information exchanges of drug discovery science as well as technology worldwide, and to facilitate a resourceful bridge for collaborations between academia and industries.
In the past four years, IDDST has demonstrated its profound impacts in terms of innovation and cooperation around the world; it has been featured as a major meeting organization for professionals in life science. As an important part of IDDST, this event will be held from November 7 to 13, 2007 in Xi'an & Beijing, China respectively. It is entitled "Advances and Challenges Toward Major Diseases", which consists of 12 outstanding workshops. Over 1000 participants are expected to join us in this 7-day exciting program.
This event provides diversified audience with a superb opportunity, both of who are general and scientific attendees, to discuss the latest developments and future trends about major diseases. We believe that it will build up a platform for pharmaceutical companies to demonstrate breakthroughs in drug discovery and to recruit R&D talents.
This symposium will be a major highlight of this year's scientific calendar and of significant benefit to all the involved. Therefore, I am writing to encourage your organization to be one of the sponsors of this event, which will surely provide your company with opportunity of being well recognized by excellent participants, and also it is a good PR opportunity to promote your company among VIP governmental decision makers in China.
Your generous sponsorship would be highly appreciated. We believe our attendees would benefit a lot from your generosity. Please let us know how we may have the pleasure of welcoming you and your company as a key sponsor of this exciting international event in November 2007.
I look forward to hearing from you. Thank you for considering this request.
Sincerely,